Results 31 to 40 of about 9,945 (164)

Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review. [PDF]

, 2023
BACKGROUND/AIMS Transjugular intrahepatic portosystemic shunts (TIPS) in patients with hepatocellular carcinoma (HCC) may improve access to curative therapies, treat portal hypertension (PH)-related complications without worsening liver function, and ...
Berzigotti, Annalisa, Bosch, Jaume, Norero, Blanca, Rodrigues, Susana G   +3 more
core   +1 more source

Management of varices and variceal hemorrhage in cirrhosis [PDF]

, 2013
Variceal hemorrhage is a lethal complication of cirrhosis, particularly in patients in whom clinical decompensation (i.e., ascites, encephalopathy, a previous episode of hemorrhage, or jaundice) has already developed.
Gonzalez R, Guadalupe Garcia-Tsao, Jaime Bosch, Laine L   +3 more
core   +2 more sources

Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis [PDF]

, 2023
Background & aims: Overt hepatic encephalopathy (OHE) is a major complication of transjugular intrahepatic portosystemic shunt (TIPS) placement, given its high incidence and possibility of refractoriness to medical treatment. Nevertheless, the impact
Adotti, Valentina, Bellafante, Daniele, Bianchini, Marcello, Caporali, Cristian, Fanelli, Fabrizio, Gioia, Stefania, Guasconi, Tomas, Indulti, Federica, Marra, Fabio, Merli, Manuela, Nardelli, Silvia, Ridola, Lorenzo, Riggio, Oliviero, Roccarina, Davide, Rosi, Martina, Saltini, Dario, Schepis, Filippo, Spagnoli, Alessandra, Vizzutti, Francesco   +18 more
core   +1 more source

TIPS and HCC: friends or foes ? [PDF]

, 2016
Portal hypertension and hepatocellular carcinoma [HCC] are major complications of liver cirrhosis and may coexist in the same patient. Transjugular intrahepatic portosystemic shunt [TIPS] is an effective treatment for recurrent variceal bleeding
DE SANTIS, Adriano
core  

Interventional treatment with the Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure may offer a preferable alternative to systemic anticoagulation in patients with cirrhosis and portal vein thrombosis [PDF]

, 2021
A clinical decision report appraising: Wang Z, Jiang MS, Zhang HL, et al. Is post-tips anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial. Radiology. 2016;279(3):943-951. https://doi.org/
Pantelic, Molly N.
core   +1 more source

25 years of experience with transjugular intrahepatic portosystemic shunt (TIPS): changes in patient selection and procedural aspects [PDF]

, 2022
Background: TIPS is an established treatment for portal hypertension. The aim was to analyze how patient selection for TIPS implantation and procedural aspects have changed over 25 years.
Aigner, Annette, Brittinger, Josefine, Böning, Georg, Büttner, Laura, Pick, Lisa, Steib, Christian J., Streitparth, Florian   +6 more
core   +1 more source

FIGO guideline on liver disease and pregnancy

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana, Virna Medina, Cynthia Maxwell, Ciara McCormick, Gloria Taliani, Ulrich Beuers, Deborah Money, Bo Jacobsson, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Graeme Smith, Lina Bergman, Sharleen O'Reilly, Patrick O'Brien, Mark Hanson, Mary Rosser, Claudio Sosa, Sumaiya Adam, Valerie Guinto, Liona Poon, Fionnuala McAuliffe, Catherine Williamson, on behalf of the FIGO Committee on Impact of Pregnancy on Long‐term Health, FIGO Committee on Infections during Pregnancy and the FIGO Division of Maternal and Newborn Health   +24 more
wiley   +1 more source

Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit

United European Gastroenterology Journal, EarlyView.
ABSTRACT Introduction Management of hepatic encephalopathy relies on the identification and control of precipitating factors (PF). The prognostic value of a PF is unknown, which we aimed to explore. Patients and Methods Single‐center retrospective study of cirrhotic patients included in a prospective cohort admitted to an intensive care unit (ICU ...
Marika Rudler, Marie de Matharel, Charlotte Bouzbib, Sarah Mouri, Lyes Kheloufi, Nicolas Weiss, Philippe Sultanik, Dominique Thabut   +7 more
wiley   +1 more source

Unlocking the potential of TIPS placement as a bridge to elective and emergency surgery in cirrhotic patients: a meta-analysis and future directions for endovascular resuscitation in acute care surgery [PDF]

, 2023
Abdominal surgery; Liver cirrhosis; Portal hypertensionCirugía abdominal; Cirrosis hepática; Hipertensión portalCirurgia abdominal; Cirrosi hepàtica; Hipertensió portalBackground In this systematic review and meta-analysis, we examined the evidence on ...
Chica, Julian, de'Angelis, Nicola, Ibn‑Abdelouahab, Abdelaziz, Jiménez Masip, Alba, Manzano-Nunez, Ramiro, Sartelli, Massimo   +5 more
core   +1 more source

Rifaximin‐α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Hepatic encephalopathy is a frequent complication of cirrhosis. Rifaximin‐α has been included in guidelines for secondary prevention of hepatic encephalopathy, but there are few real‐world data on its efficacy and impact on healthcare utilization.
Diederick J. van Doorn, Kirsi. M. A. van Eekhout, Koos de Wit, L. C. Baak, Michael Klemt‐Kropp, Bart J. Verwer, Philip Friederich, Gijs J. de Bruin, Xander G. Vos, Joost P. H. Drenth, R. Bart Takkenberg   +10 more
wiley   +1 more source